1998
DOI: 10.1016/s0003-9969(97)00092-7
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of the clinical value of total saliva flow rates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
38
0
12

Year Published

2005
2005
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(56 citation statements)
references
References 11 publications
5
38
0
12
Order By: Relevance
“…Xerostomia was reported by 68.9% of the 90 participants in our observational study, which also agreed with other studies (19,25). Measurement of UWS is the most reliable method for quantifying the salivary function (38), and the mean UWS (0.162 Ϯ 0.107 ml/min) of our patients was significantly lower than the normal reference value of 0.25 to 0.5 ml/min (35). We also found that hyperdipsic patients had extremely low baseline UWS (0.09 ml/min in the pilot study [ Figure 3]; 0.11 and 0.09 ml/min in each group, respectively, in the interventional trial [ Tables 4 and 6]), which was comparable with that of patients who received radiotherapy for head and neck tumors (0.113 ml/min) (39).…”
Section: Discussionsupporting
confidence: 93%
“…Xerostomia was reported by 68.9% of the 90 participants in our observational study, which also agreed with other studies (19,25). Measurement of UWS is the most reliable method for quantifying the salivary function (38), and the mean UWS (0.162 Ϯ 0.107 ml/min) of our patients was significantly lower than the normal reference value of 0.25 to 0.5 ml/min (35). We also found that hyperdipsic patients had extremely low baseline UWS (0.09 ml/min in the pilot study [ Figure 3]; 0.11 and 0.09 ml/min in each group, respectively, in the interventional trial [ Tables 4 and 6]), which was comparable with that of patients who received radiotherapy for head and neck tumors (0.113 ml/min) (39).…”
Section: Discussionsupporting
confidence: 93%
“…The SS Disease Activity Index (SSDAI) score 26 and visual analog scale (VAS) for assessment of disease impact were assessed, and blood samples were taken for laboratory examinations, including hemoglobin, alanine aminotransferase, and aspartate aminotransferase, for each patient at each follow-up visit. For those with severe xerostomia and/or xerophthalmia at baseline, assessments performed at these time points included salivary flow rate test, determination of modified Treatment Emergent Symptom Scale for xerostomia score, 27 and sialography. Systemic improvements were graded by VAS score and SSDAI score at each visit time for those without obvious xerostomia and/or xerophthalmia at baseline.…”
Section: Follow-up Proceduresmentioning
confidence: 99%
“…Unstimulated whole saliva was collected, as it is more sensitive for detecting salivary characteristics (12). After saliva sampling, appointments were scheduled to treat existing dental caries, and the children were asked to continue their previous routine oral hygiene practices.…”
Section: Study Proceduresmentioning
confidence: 99%